FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111800737> ?p ?o ?g. }

• W2111800737 endingPage "208" @default.
• W2111800737 startingPage "205" @default.
• W2111800737 abstract "To investigate the relationship between recurrence of uveitis and timing of infliximab in patients with Behçet's disease.Charts were retrospectively reviewed for 23 patients with refractory uveoretinitis associated with Behçet's disease treated using infliximab at our hospital. Infliximab was administered by intravenous infusion at weeks 0, 2 and 6, and every 8 weeks thereafter. The relationship between recurrence of uveitis and infliximab infusion was analysed.Mean duration of infliximab treatment for the 23 patients was 20 months, and the mean number of infliximab infusions was 12. Recurrent uveitis was seen during treatment in 13 of 23 patients, with no recurrences in the remaining 10 patients. Two patients developed recurrence soon after starting treatment-for example, first recurrence after starting infliximab was on day 19 or day 29, but the other 11 patients experienced recurrences after 5-6 months of infliximab treatment. As regards the timing of recurrences following infliximab infusion, 10 of the 13 patients developed recurrences ∼5 weeks after infliximab infusion. Recurrent uveitis in these patients most often occurred during weeks 7-8 after infusion. However, three of the patients developed recurrent uveitis at various times, for example in weeks 1, 4, 7 and 8 after infliximab infusion.Infliximab is effective for suppressing recurrence of uveitis in Behçet's disease, but responses to infliximab differ among patients. Careful observation following infliximab infusion is necessary to manage the recurrence of uveitis during treatment." @default.
• W2111800737 created "2016-06-24" @default.
• W2111800737 creator A5007816743 @default.
• W2111800737 creator A5013441846 @default.
• W2111800737 creator A5029122307 @default.
• W2111800737 creator A5040963064 @default.
• W2111800737 creator A5042940760 @default.
• W2111800737 creator A5084495215 @default.
• W2111800737 date "2010-06-11" @default.
• W2111800737 modified "2023-10-18" @default.
• W2111800737 title "Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment" @default.
• W2111800737 cites W1982017993 @default.
• W2111800737 cites W1985763670 @default.
• W2111800737 cites W1991528145 @default.
• W2111800737 cites W1996472975 @default.
• W2111800737 cites W2011296007 @default.
• W2111800737 cites W2020804331 @default.
• W2111800737 cites W2025008711 @default.
• W2111800737 cites W2026342001 @default.
• W2111800737 cites W2031444002 @default.
• W2111800737 cites W2036131677 @default.
• W2111800737 cites W2037998678 @default.
• W2111800737 cites W2038457542 @default.
• W2111800737 cites W2040235283 @default.
• W2111800737 cites W2044160586 @default.
• W2111800737 cites W2049056531 @default.
• W2111800737 cites W2056596058 @default.
• W2111800737 cites W2065751261 @default.
• W2111800737 cites W2074807009 @default.
• W2111800737 cites W2087716361 @default.
• W2111800737 cites W2104966068 @default.
• W2111800737 cites W2121628076 @default.
• W2111800737 cites W2143190437 @default.
• W2111800737 cites W2147171610 @default.
• W2111800737 cites W2155987419 @default.
• W2111800737 cites W2158200396 @default.
• W2111800737 cites W2158286914 @default.
• W2111800737 cites W2171341132 @default.
• W2111800737 cites W2473433727 @default.
• W2111800737 doi "https://doi.org/10.1136/bjo.2009.168856" @default.
• W2111800737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20542984" @default.
• W2111800737 hasPublicationYear "2010" @default.
• W2111800737 type Work @default.
• W2111800737 sameAs 2111800737 @default.
• W2111800737 citedByCount "42" @default.
• W2111800737 countsByYear W21118007372012 @default.
• W2111800737 countsByYear W21118007372013 @default.
• W2111800737 countsByYear W21118007372014 @default.
• W2111800737 countsByYear W21118007372015 @default.
• W2111800737 countsByYear W21118007372016 @default.
• W2111800737 countsByYear W21118007372017 @default.
• W2111800737 countsByYear W21118007372018 @default.
• W2111800737 countsByYear W21118007372019 @default.
• W2111800737 countsByYear W21118007372020 @default.
• W2111800737 countsByYear W21118007372021 @default.
• W2111800737 countsByYear W21118007372022 @default.
• W2111800737 countsByYear W21118007372023 @default.
• W2111800737 crossrefType "journal-article" @default.
• W2111800737 hasAuthorship W2111800737A5007816743 @default.
• W2111800737 hasAuthorship W2111800737A5013441846 @default.
• W2111800737 hasAuthorship W2111800737A5029122307 @default.
• W2111800737 hasAuthorship W2111800737A5040963064 @default.
• W2111800737 hasAuthorship W2111800737A5042940760 @default.
• W2111800737 hasAuthorship W2111800737A5084495215 @default.
• W2111800737 hasConcept C118487528 @default.
• W2111800737 hasConcept C121332964 @default.
• W2111800737 hasConcept C126322002 @default.
• W2111800737 hasConcept C141071460 @default.
• W2111800737 hasConcept C142424586 @default.
• W2111800737 hasConcept C167135981 @default.
• W2111800737 hasConcept C2776194053 @default.
• W2111800737 hasConcept C2777138892 @default.
• W2111800737 hasConcept C2779134260 @default.
• W2111800737 hasConcept C2781428731 @default.
• W2111800737 hasConcept C71924100 @default.
• W2111800737 hasConcept C87355193 @default.
• W2111800737 hasConceptScore W2111800737C118487528 @default.
• W2111800737 hasConceptScore W2111800737C121332964 @default.
• W2111800737 hasConceptScore W2111800737C126322002 @default.
• W2111800737 hasConceptScore W2111800737C141071460 @default.
• W2111800737 hasConceptScore W2111800737C142424586 @default.
• W2111800737 hasConceptScore W2111800737C167135981 @default.
• W2111800737 hasConceptScore W2111800737C2776194053 @default.
• W2111800737 hasConceptScore W2111800737C2777138892 @default.
• W2111800737 hasConceptScore W2111800737C2779134260 @default.
• W2111800737 hasConceptScore W2111800737C2781428731 @default.
• W2111800737 hasConceptScore W2111800737C71924100 @default.
• W2111800737 hasConceptScore W2111800737C87355193 @default.
• W2111800737 hasIssue "2" @default.
• W2111800737 hasLocation W21118007371 @default.
• W2111800737 hasLocation W21118007372 @default.
• W2111800737 hasOpenAccess W2111800737 @default.
• W2111800737 hasPrimaryLocation W21118007371 @default.
• W2111800737 hasRelatedWork W2090086918 @default.
• W2111800737 hasRelatedWork W2417066483 @default.
• W2111800737 hasRelatedWork W2936891385 @default.
• W2111800737 hasRelatedWork W2953850901 @default.
• W2111800737 hasRelatedWork W4225613530 @default.

• next